Press Releases:
Click on the links below to view recent press releases.

IBI Announces Departure of President & CEO, Joe Hernandez ROCKVILLE, MD, August 10, 2009 — Joe Hernandez, Founder, President & CEO of Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, announced his resignation effective August 7, 2009.  Hernandez will continue to advise the company for several months thereafter. (view PDF)

Thermo Fisher Scientific and Innovative Biosensors Form Strategic Relationship ROCKVILLE, MD, June 16, 2009 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, and Thermo Fisher Scientific, Inc., the world leader in serving science, announced today that they had entered into a manufacturing and distribution agreement.
(view PDF)

Innovative Biosensors and ProGenTech Partner to Develop a Rapid Diagnostics System ROCKVILLE, MD and EMERYVILLE, CA, February 24, 2009 — Innovative Biosensors, Inc. (IBI), and ProGenTech Limited, two emerging leaders in life science & diagnostics, today announced an agreement to jointly develop a rapid, integrated diagnostic system. The system will incorporate Innovative Biosensor’s proprietary Cellular Analysis and Notification of Antigen Risks and Yields (“CANARY®”) technology, a cell-based approach for quickly detecting various pathogens, into a modified version of ProGenTech’s Entura Lite™ platform with integrated optical detection capabilities. IBI will commercialize the developed product and financial terms of the deal were not disclosed. (view PDF)

Innovative Biosensors Inc. Expands Scientific Advisory Board ROCKVILLE, MD, August 5, 2008 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the clinical and biodefense markets, today announced the expansion of its Scientific Advisory Board. (view PDF)

Innovative Biosensors Inc. Raises $11.5 Million — Series B Financing Combines Equity and Debt Capital ROCKVILLE, MD, May 19, 2008 — Innovative Biosensors Inc. (IBI), a company developing rapid, ultra-sensitive tests to identify harmful pathogens, today announced the completion of an $11.5 million Series B financing which included equity and debt. The Series B was led by Life Sciences Partners (LSP), of Boston, Mass and involved $9.5M in equity capital. The company also increased its existing debt facility to $2 million from Silicon Valley Bank, a member company of SVB Financial Group (Nasdaq: SIVB). (view PDF)

Innovative Biosensors Inc. and ATCC® Partner to Develop High-speed Test for Avian Flu ROCKVILLE, MD and MANASSAS, VA, April 9, 2008 — Innovative Biosensors Inc. and ATCC today announced a research and development partnership aimed at developing a rapid and portable test to detect Avian (H5N1) influenza virus. (view PDF)

Innovative Biosensors, Inc. Announces Formation of a Dedicated Enviromental Business Group — Sales-focused Operating Unit to Expand Commercial Potential of BioFlash-E™ Biological Identifier ROCKVILLE, MD March 31, 2008 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, today announced the creation of the IBI Environmental Business Group, to be led by Richard Thomas as President. Joe Hernandez remains as CEO of IBI and President of the Clinical Business Group. (view PDF)

Biological Hazard Monitoring Innovators Team to Distribute Systems for Rapid BioThreat Assessment — Innovative Biosensors, Inc. and Universal Detection Technology Partner on Biological Detection and Identification Systems for Environmental Monitoring ROCKVILLE, MD and LOS ANGELES, CA, March 17, 2008 — Two bio-monitoring technology producers have come together to address the market need for bio-threat detectors for clients dependent on accurate, rapid environmental assessments. (view PDF)

Innovative Biosensors, Inc. and SecureTeq Corporation Partner to Integrate Technologies for Biodefense Security Management ROCKVILLE, MD,
March 3, 2008 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, and SecureTeq Corporation, a company providing proprietary software coupled with unique services and solutions for business continuity, commercial and government building security, today announced that they have formed a partnership to integrate and commercialize facility and infrastructure security management systems globally. (view PDF)

Innovative Biosensors, Inc. and the University of Maryland Receive Funding for Handheld Biosensor Development ROCKVILLE, MD, February 25, 2008 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, today announced the company’s selection for funding for a partnership proposal, with the A. James Clark School of Engineering at the University of Maryland, from The National Consortium for Measurement and Signatures Intelligence (MASINT) Research NCMR. (view PDF)

ENVIRONMENTAL MONITORS ALLY FOR SPEED ON BIO-THREAT ASSESSMENT; NEW COMBINED SYSTEM CUTS TIME FOR ACTION ON MONITORED THREATS – Innovative Biosensors, Inc. and BioVigilant Systems, Inc., Partner on Biological Detection & Warning Systems for Environmental Monitoring ROCKVILLE, MD and TUCSON, AZ, January 14, 2008 — Two bio-monitoring technology companies have joined to speed rugged, portable bio-threat detectors for clients dependent on accurate, quick environmental assessments. (view PDF)

Innovative Biosensors, Inc. Launches BioFlash-E™ Biological Detector ROCKVILLE, MD, November 13, 2007 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, today announced that it has launched the BioFlash-E™ Biological Aerosol Collection, Detection and Identification System. (view PDF)

Innovative Biosensors, Inc. to Present at Acumen BioFin™  Rodman & Renshaw Global Healthcare Conference ROCKVILLE, MD, October 31, 2007 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the clinical infectious disease and biodefense markets, today announced that Joe Hernandez, President and Chief Executive Officer, has been invited to present at the Acumen BioFin™ Rodman & Renshaw 9th Annual Global Healthcare Conference on November 5-7 in New York City. (view PDF)

Innovative Biosensors, Inc. (IBI) Invited to Present at Mid-Atlantic Bio and MAC Alliance Conferences ROCKVILLE, MD, October 18, 2007 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the clinical infectious disease and biodefense markets, today announced that Joe Hernandez, President and Chief Executive Officer, has been invited to present at the MAC Alliance Conference on October 23-24 at the Philadelphia Marriott, as well as the 2007 Mid-Atlantic Bio Conference on October 24-26 at the North Marriott Conference Center in Bethesda, MD. (view PDF)

Innovative Biosensors, Inc. (IBI) Awarded $1.6 Million Contract for Biological Defense of Critical Buildings ROCKVILLE, MD, October 2, 2007 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, today announced that it has been awarded a contract to provide reagents and technical support for the proprietary CANARY™ technology-based detection and identification system installed and implemented at one of the most important structures in the National Capitol Region. (view PDF)

Innovative Biosensors, Inc. (IBI) Adds Senior Vice President of Research and Development ROCKVILLE, MD, July 11, 2007 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the clinical and biodefense markets, today announced the hiring of Venkatakrishna Shyamala, Ph.D. as Senior Vice President of Research and Development. (view PDF)

Innovative Biosensors, Inc. (IBI) Announces Relocation of Operations to The Red Cross’ Jerome Holland Laboratory Facility in Rockville, MD. ROCKVILLE, MD, May 15, 2007 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the clinical and biodefense markets, today announced that it has graduated from the University of Maryland College Park, Technology Advancement Program (TAP) Incubator. IBI has relocated its operations to the Red Cross’ Jerome Holland Laboratory facility in Rockville, Maryland. (view PDF)

Innovative Biosensors, Inc. (IBI) to Present at Acumen Rodman & Renshaw Conference ROCKVILLE, MD, May 10, 2007 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the clinical and biodefense markets, today announced that Joe Hernandez, President and Chief Executive Officer, has been invited to present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference on May 14, 2007. The conference will take place in Monte Carlo, Monaco. (view PDF)

Innovative Biosensors, Inc. (IBI) Announces Expansion Of Senior Management Team COLLEGE PARK, MD, February 21, 2007 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced the expansion of it’s Senior Management Team to increase the breadth of resources dedicated to the commercialization of the technology. IBI welcomes Joanne Stephenson as Head of Strategic Marketing and Richard Thomas as VP Business Development. (view PDF)

Innovative Biosensors, Inc. (IBI) Expands A Round Financing to Total of $6.25 Million COLLEGE PARK, MD, October 16, 2006 — Innovative Biosensors Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced that it has expanded its A round to $6.25 Million in total financing with additional investors, including Chart Venture Partners and CNF Investments, LLC, an affiliate of Clark Enterprises, Inc. (CEI). (view PDF)

Innovative Biosensors, Inc.’s Scientific Team and its President and CEO, Joe Hernandez, Receive The Daily Record’s 2006 Innovator of the Year Award COLLEGE PARK, MD, October 3, 2006 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced that it is one of several recipients of The Daily Record’s Innovator of the Year 2006 Award. (view PDF)

Innovative Biosensors, Inc.’s President and CEO, Joe Hernandez, to Speak at the Dow Jones VentureWire Health Care Innovations 2006 Conference and the Rodman & Renshaw 8th Annual Healthcare Conference. COLLEGE PARK, MD, August 15, 2006 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced that its President and CEO, Joe Hernandez, has accepted invitations to speak at two upcoming conferences. (view PDF)  

Phil Samper to Join Board of Innovative Biosensors, Inc. COLLEGE PARK, MD, February 21, 2006 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced that Phil Samper, formerly of Eastman Kodak and Sun Microsystems, will join its Board of Directors. (view PDF)

Robin Toft to Join Board of Innovative Biosensors, Inc. COLLEGE PARK, MD, January 9, 2006— Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced that Robin Toft, formerly of Roche Molecular Systems, Inc., will join its Board of Directors. (view PDF)

Innovative Biosensors, Inc. and Cambrex Establish Manufacturing Relationship COLLEGE PARK, MD and East Rutherford, NJ — October 4, 2005 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, and Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex Corporation (NYSE: CBM), today announced that they have signed an agreement for Cambrex to supply cGMP manufacturing services. (view PDF)

Innovative Biosensors, Inc. Establishes Scientific Advisory Board COLLEGE PARK, MD, September 19, 2005 — Innovative Biosensors, Inc (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced the establishment of its Scientific Advisory Board. Innovative Biosensors, Inc. develops and manufactures pathogen tests for infectious diseases within the food safety and human clinical markets. IBI has established a Scientific Advisory Board of prominent individuals with exceptional experience in both of these markets. The Board includes Dr. Arnold N. Weinberg and Dr. Edward R. Richter. (view PDF)

Innovative Biosensors, Inc. Raises $3.5 Million in Series A Financing COLLEGE PARK, MD, May 26, 2005 – Innovative Biosensors, Inc (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced that it has raised $3.5 Million in Series A financing led by Harbert Venture Partners, LLC. Other investors include New Markets Growth Fund and the Maryland Venture Fund. (view PDF)

Innovative Biosensors, Inc. Receives 2005 Maryland Incubator Company of the Year Award for Best Life Science Company COLLEGE PARK, MD, May 17, 2005 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced that it has received the 2005 Maryland Incubator Company of the Year Award for Best Life Science Company. (full text)

Innovative Biosensors, Inc. Receives Frost & Sullivan 2005 Technology Leadership Award. COLLEGE PARK, MD, April 13, 2005 — Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced that it has received the prestigious 2005 Technology Leadership Award from Frost & Sullivan, a global growth consulting firm. (view PDF)

Innovative Biosensors is Awarded Over $162,000 in Grants from the State of Maryland. Gaithersburg, MD, PRNewswire "Innovative Biosensors Inc., a privately held developer of rapid diagnostic technologies today announced that it has been awarded a matching grant from The Maryland Industrial Partnership (MIPS) Program valued at $112,148 and $50,000 from The Maryland Technology Development Corporation (TEDCO) through its Maryland Technology Transfer Fund (MTTF) program." PRNewswire, January 27, 2004. (full text)

Innovative Biosensors and Massachusetts Institute of Technology Announce Licensing Agreement for Biosensor Technology. Gaithersburg, MD, PRNewswire "Innovative Biosensors Inc., a privately held pioneering developer of rapid diagnostic technologies, today announced that the Company has obtained an exclusive license for the CANARY™ biosensor technology developed at Massachusetts Institute of Technology (MIT) Lincoln Laboratory." PRNewswire, November 20, 2003.(full text)